Investor Presentation

Kopran's Q1 FY26-27 revenue climbed 13.88% YoY to **153.99 Cr** (from 135.22 Cr). EBITDA also rose 11.13% YoY, hitting **15.88 Cr**. However, Net Profit dipped 10.19% YoY to **6.70 Cr**, with EPS at Rs. 1.39. The API segment was the largest contributor with **95.38 Cr** revenue, while Formulations generated **57.09 Cr** from international exports to various markets.

Strategic focus areas include R&D for niche, high-value APIs and capacity expansion, notably an API and R&D facility planned for Panoli.

The company is actively working on cost optimization, process improvements, and reducing reliance on specific regions.

Kopran aims for sustainable growth by expanding its customer base, entering new geographies, and increasing regulatory filings, while ensuring global quality standards and leveraging synergies between its API and formulations businesses.